DKSH Holding Ltd. turns to Korea's distribution market

Published: 2004-10-22 07:00:00

Updated: 2004-10-22 07:00:00

Pharmaceutical business sources said a Swiss-based DKSH (Diethelm Keller SiberHegner) Holding Ltd. is tapping the possibility to expand its presence in the domestic distribution market in the not-too-distant future, meaning that Zuellig Korea will face an uphill battle in the years to come.

Fo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK